(Q53070213)

English

Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer.

scientific article published on 25 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24464532

Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24464532

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Martin Schäfer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Ulrike Bauder-Wüst

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Uwe Haberkorn

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Michael Eisenhut

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

25 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24464532

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

74

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

659-668

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464532%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

Prostate-specific membrane antigen expression as a predictor of prostate cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

An update of radiolabeled bombesin analogs for gastrin-releasing peptide receptor targeting

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

(18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FB-PEG3-Glu-RGD-BBN.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

(68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

PSMA as a target for radiolabelled small molecules

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

64Cu-NO2A-RGD-Glu-6-Ahx-BBN(7-14)NH2: a heterodimeric targeting vector for positron emission tomography imaging of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

Pseudoirreversible inhibition of prostate-specific membrane antigen by phosphoramidate peptidomimetics

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22784

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53070213&oldid=1196734251"